- Exchange: London
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Smith & Nephew PLC
+ Add to WatchlistSN/:LN
777.000 GBp 6.500 0.83%As of 11:35:28 ET on 05/17/2013.
Snapshot for Smith & Nephew PLC (SN/)
| Open: | 779.000 | Day's Range: | 774.500 - 784.000 | Volume: | 1,705,712 |
|---|---|---|---|---|---|
| Previous Close: | 783.500 | 52wk Range: | 567.500 - 788.000 | 1-Yr Rtn: | +37.21% |
Key Statistics for SN/
| Current P/E Ratio (ttm) | 14.8632 |
|---|---|
| Estimated P/E(12/2013) | 15.3579 |
| Relative P/E vs. UKX | 0.8679 |
| Earnings Per Share (USD) (ttm) | 0.7930 |
| Est. EPS (USD) (12/2013) | 0.7680 |
| Est. PEG Ratio | 2.1868 |
| Market Cap (M GBP) | 7,040.65 |
| Shares Outstanding (M) | 906.13 |
| 30 Day Average Volume | 1,545,697 |
| Price/Book (mrq) | 2.6979 |
| Price/Sale (ttm) | 2.5599 |
| Dividend Indicated Gross Yield | 2.40% |
| Cash Dividend (USD) | 0.1620 |
| Last Dividend | 04/17/2013 |
| 5 Year Dividend Growth | 23.28% |
| Next Earnings Announcement | 08/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SN/
Company Profile & Key Executives for SN/
Smith & Nephew plc develops and markets advanced medical devices. The Group is involved in orthopaedics, endoscopy, and advanced wound management.
| Olivier BohuonChief Executive Officer | Julie BrownChief Financial Officer |
| Ros RivazChief Technology Officer | Helen MayeChief Human Resources Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
SN/ News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page